Drugs to add independent living time with Alzheimer's
Public Domain by Garrondo
A new study finds that two drugs, lecanemab and
donanemab, can add on average 10 and 13 additional months of
independent living to patients with beginning Alzheimer's disease.
Contact: info@neat-news.com.
neat-news.com is not responsible for the content of external sites.
We do not link to external sites in return for money or any other benefits.
The page is maintained in Germany and for any legal matters the laws of Germany apply.
Any warranty or liability is excluded in the widest legally possible sense.